ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,305.23
-3.97%
S&P 500
5,116.17
0.32%
Dow Jones
38,386.09
0.38%
US Dollar vs Yen
156.935
0.39%
Brent Oil
87.565
0.32%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Kiniksa Pharmaceuticals Ltd (KNSA)

  7. Kiniksa Pharmaceuticals Ltd (KNSA) ニュース

KNSA Kiniksa Pharmaceuticals Ltd

18.55
0.00 (0.00%)
プレマーケット
最終更新日： 20:00:11
15分遅延
名称 銘柄コード 市場 種別
Kiniksa Pharmaceuticals Ltd KNSA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 18.55 20:00:11
始値 安値 高値 終値 前日終値
18.55
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2320:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
2024/4/1705:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
2024/4/0220:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
2024/3/0606:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:29EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0106:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2821:35EDGAR2Form 8-K - Current report
2024/2/2821:30GLOBEKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
2024/2/2807:06EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2206:01GLOBEKiniksa Pharmaceuticals to Report Fourth Quarter and..
2024/2/1506:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1505:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0506:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0421:37EDGAR2Form 8-K - Current report
2024/1/0421:30GLOBEKiniksa Pharmaceuticals Provides Corporate Update
2024/1/0406:55EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0306:01GLOBEKiniksa Pharmaceuticals to Present at 42nd Annual J.P...
2023/12/1206:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0806:46EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/3120:35EDGAR2Form 8-K - Current report
2023/10/3120:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/10/2505:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2023..
2023/9/0708:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0708:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0708:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0708:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0606:26EDGAR2Form 144 - Report of proposed sale of securities
2023/8/1905:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/8/1105:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/8/0205:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2805:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2606:14EDGAR2Form 144 - Report of proposed sale of securities
2023/7/2520:40EDGAR2Form 8-K - Current report
2023/7/2520:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2023..
2023/7/1721:00GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2023..
2023/6/0705:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 44th..
2023/5/0220:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2023 Financial..
2023/5/0205:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2023..

最近閲覧した銘柄

NASDAQ
KNSA
Kiniksa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有